MYCN and medulloblastoma: We corroborated the microarray data with qRT-RTPCR in 12 primary medulloblastomas and determined that MYCN was not significantly overexpressed in tumors with gain or amplifications of 2p, compared to others (p = 0.31) [Table 4].